Vorapaxar Sulfate API (CAS 705260-08-8): Enhancing Cardiovascular Health
Discover the potent antiplatelet solution for reducing major cardiovascular events and improving patient outcomes.
Get a Quote & SampleProduct Core Value
Vorapaxar Sulfate
Vorapaxar Sulfate is a state-of-the-art active pharmaceutical ingredient (API) crucial for developing advanced antiplatelet medications. As a selective PAR-1 antagonist, it plays a vital role in preventing thrombotic events, offering a significant advantage in cardiovascular disease management.
- High Purity Vorapaxar Sulfate: Our API consistently exceeds 99% assay, ensuring top-tier quality for your pharmaceutical formulations.
- Targeted PAR-1 Antagonist: Vorapaxar Sulfate acts as a potent thrombin receptor antagonist, inhibiting platelet aggregation through a distinct mechanism.
- Essential for Cardiovascular Event Prevention: Clinically proven to reduce the risk of myocardial infarction and stroke, crucial for patients with peripheral arterial disease management.
- Reliable Antiplatelet Drug Component: Integrate our Vorapaxar Sulfate API into your antiplatelet drug formulations for enhanced efficacy and patient safety.
Product Advantages
Enhanced Thrombosis Prevention
By inhibiting thrombin-related platelet aggregation, our Vorapaxar Sulfate offers a unique approach to antiplatelet therapy, preventing critical cardiovascular events.
Superior API Quality
Our high-purity Vorapaxar Sulfate API ensures reliable performance and consistent results for pharmaceutical manufacturers seeking the best antiplatelet drug Vorapaxar Sulfate.
Critical for Patient Outcomes
Incorporating this PAR-1 antagonist into treatments for conditions like myocardial infarction treatment or peripheral arterial disease management significantly improves patient prognosis.
Key Applications
Cardiovascular Disease Management
Used in advanced formulations for patients with a history of myocardial infarction to reduce the risk of future cardiovascular death, MI, and stroke.
Peripheral Arterial Disease Treatment
Essential for drugs targeting peripheral arterial disease management, helping to prevent thrombotic complications and improve vascular health.
Antiplatelet Drug Development
A core active pharmaceutical ingredient for the creation of next-generation antiplatelet drugs, offering a novel mechanism of action.
Thrombosis Prevention Therapies
Utilized in medications designed for comprehensive thrombosis prevention, especially for patients at high risk of atherothrombotic events.